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Abstract:  Injury to growth plate cartilage in children can lead to bone bridge formation and result in bone growth 
deformities, a significant clinical problem currently lacking biological treatment. Mesenchymal stem/stromal cells (MSC) 
offer a promising therapeutic option for regeneration of damaged cartilage, due to their self renewing and multi-lineage 
differentiation attributes. Although some small animal model studies highlight the therapeutic potential of MSC for 
growth plate repair, translational research in large animal models, which more closely resemble the human condition, are 
lacking. Our laboratory has recently characterised MSCs derived from ovine bone marrow, and demonstrated these cells 
form cartilage-like tissue when transplanted within the gelatin sponge, Gelfoam, in vivo. In the current study, autologous 
bone marrow MSC were seeded into Gelfoam scaffold containing TGF-1, and transplanted into a surgically created 
defect of the proximal ovine tibial growth plate. Examination of implants at 5 week post-operatively revealed transplanted 
autologous MSC failed to form new cartilage structure at the defect site, but contributed to an increase in formation of a 
dense fibrous tissue. Importantly, the extent of osteogenesis was diminished, and bone bridge formation was not 
accelerated due to transplantation of MSCs or the gelatin scaffold. The current study represents the first work that has 
utilised this ovine large animal model to investigate whether autologous bone marrow derived MSC can be used to initiate 
regeneration at the injured growth plate. 
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INTRODUCTION 
  The identification of self renewing multipotential 
progenitor cells from adult stromal tissues has stimulated 
significant interest and promise for the utilisation of these 
cells in regenerative medicine and tissue engineering. Since 
the discovery of putative mesenchymal stem/stromal cells 
(MSC) from bone marrow suspensions [1] with the ability to 
form adherent clonogenic clusters (CFU-F), and capacity to 
differentiate into a multitude of cell types in vitro and in 
vivo, MSCs have now been isolated from numerous 
connective tissues [2]. In addition, MSCs appear to share 
similar characteristics across species, which has facilitated 
the application of MSC in translational studies using animal 
models. 
  The growth plate is a unique cartilaginous tissue located 
at the proximal and distal ends of the long bones of children, 
and is responsible for longitudinal bone growth until closure 
at skeletal maturity. Due to the avascular and alymphatic 
nature of cartilage, once damaged, cartilage has a poor   
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regenerative capacity. Injury to growth plate cartilage often 
results in an undesirable repair response mechanism at the 
site of injury, where ossification of the damaged tissue may 
lead to formation a bone bridge. Establishment of a bone 
bridge across the growth plate can have serious 
consequences in children, and may lead to limb length 
discrepancies and angular deformity. Current treatments of 
limb abnormalities include surgical correction of angularity 
or length discrepancy after manifestation of the deformity. 
To date, there is no cell-based biological based therapy to 
prevent bone bridge formation and regenerate the damaged 
growth plate cartilage in clinical practice [2]. 
  Although there have been some recent investigations in 
rabbit or rodent models examining potential applications of 
MSCs in repairing injured growth plate with some success 
[3-6], the therapeutic potential of MSCs in growth plate 
regeneration remains to be investigated in a large animal 
model. The use of sheep as a large animal model for 
orthopaedic research continues to increase in popularity due 
to similarities with humans in weight, size, joint structure, 
bone/cartilage regenerative processes, and thus the potential 
in translational research. 
  Our laboratory has undertaken numerous studies 
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growth plate injury repair, techniques for the prevention of 
bone bridge formation, and reversal of skeletal deformity [7-
13]. Several interpositional materials have been assessed for 
their potential to impede or prevent bone formation and 
regenerate the damaged cartilage. These include fat, cultured 
chondrocytes [7, 9], cartilage [11], periosteum [11], and a 
type 1 collagen paste [12]. 
  We have recently described the functional and 
phenotypic properties of ovine bone marrow derived MSCs, 
including incidence, immunophenotype, proliferative response 
to mitogens, and differentiation potential both in vitro and in 
vivo [14]. In this pilot study the potential of autologous 
MSCs to repair damaged growth plate cartilage in an 
immature ovine model was investigated. 
MATERIALS AND METHODS 
Subjects and Cell Culture 
  All procedures were approved by the institutional animal 
ethics committee and performed under sterile conditions. 
Fresh bone marrow aspirates were obtained from the iliac 
crest of 5 lambs (approximately 8 weeks old) under general 
anaesthesia according to procedures approved by the ethics 
committee of the Women’s & Children’s Hospital, South 
Australia. Bone marrow mononuclear cells (BM MNC) were 
isolated by centrifugation of aspirates on a Lymphoprep
™ 
density gradient (S.G. 1.077 g/ml) (Axis Shield or Nycomed, 
Oslo, Norway) as previously described [15, 16]. 
Ovine Primary Mesenchymal Stem Cell Cultures 
  Briefly, single cell suspensions of BM MNC were plated 
in monolayer in -MEM media supplemented with penicillin 
(50 i.u./ml)/streptomycin sulphate (50 μg/ml), 10% (v/v) 
fetal calf serum (FCS; SAFC Biosciences, Lenexa, KS), 2 
mM L-glutamine (SAFC Biosciences), 1 mM sodium 
pyruvate (SAFC Biosciences), and 100 μM L-ascorbate-2-
phosphate (Asc-2-P, WAKO Pure Chemical Industries Ltd, 
Osaka, Japan) and incubated at 37°C in the presence of 5% 
CO2. After 3 days, non adherent cells were removed and 
fresh media replaced. Upon confluence, cells were detached 
by enzymatic digestion in 0.05% (w/v) trypsin (Gibco, 
Invitrogen, Carlsbad, CA, USA) and 0.5 mM EDTA (BDH 
AnalaR
®, Merck) in sterile PBS. 
Transplantation of Autologous MSC to Growth Plate 
Defect in Lambs 
  Four million lamb MSCs (P1) were resuspended in serum 
replete chondrogenic media containing growth factor TGF-
1 (10 ng/ml) and statically seeded onto Gelfoam sponge 
(Pharmacia & Upjohn) (approximately 10 x 8 mm squares). 
The MSC were consolidated within the Gelfoam sponge 
using a fibrin clot (gift from Mr. Rick Tocchetti, IMVS, 
Adelaide, Australia). 
  The procedure for creation of a small (10 mm deep x 10 
mm wide x 5 mm high) growth plate defect at the proximal 
tibia of lambs has been established previously by Foster et 
al. [9, 13]. The defect site was immersed in 100 μl of 1 
Unit/ml Chondroitinase ABC (Sigma-Aldrich), which was 
removed by aspiration and blotted dry after 5 mins. The 
Gelfoam scaffold with or without MSCs was placed within 
the defect site. Nine lambs were divided into two groups. 
One group (n=5) received a growth plate defect on both hind 
legs, with one defect on one limb being filled with Gelfoam 
scaffold in chondrogenic media containing no cells, with the 
defect on the contralateral limb receiving the Gelfoam 
scaffold seeded with 4 x 10
6 autologous MSC. The other 
group (n = 4) received an untreated defect on one limb and 
the contralateral limb was uninjured as a normal control. 
Two titanium Kirschener wires (K-wires) were inserted after 
wound closure perpendicular to the growth plate, in the 
epiphysis and diaphysis respectively, using a F-shaped 
template of 20 mm separation, in order to facilitate the 
precise measurement of limb growth following partial 
growth plate disturbance. 
  All animals were sacrificed five weeks post-operatively. 
In order to perfuse, fix, and collect tissue specimens, animals 
were sedated and general anaesthesia was induced as 
previously described [9, 13]. Following catheterisation the 
leg was perfused with 500ml of 1% sodium nitrite in 0.1 M 
phosphate buffer. During the sodium nitrite perfusion, the 
animal was euthanized by an overdose of sodium 
pentobarbitone (10ml, Lethabarb, Virbac, Milperra, NSW, 
Australia). Subsequently, each leg was perfused with 500 ml 
of 10% buffered formalin. The hind leg was removed and the 
portion (15 mm x 15 mm x 15 mm) containing the defect 
was excised using an Isomet Low Speed Saw (Buehler Ltd., 
Lake Bluff, IL, USA) and placed in a solution of 10% 
buffered formalin for 48 hours. Following fixation, the 
sample was decalcified in Immunocal (United Biosciences, 
Carindale, Qld, Australia) for 7 days and processed for 
paraffin embedding, from which 5 μm sections were cut and 
stained with Haematoxylin, Eosin, and 1% Alcian Blue. 
Growth Plate Injury Repair Measurements and 
Statistical Analysis 
  Measurement of the area representative of different repair 
tissue types (mesenchymal, bone, cartilage, marrow, and fat) 
within lamb growth plate defects was performed using the 
Olysia BioReport software imaging system (Olympus 
Corporation, Tokyo, Japan). Measurements were taken 
within a defined area adjacent to the intact growth plate and 
calculated as the percentage of the total area measured [17]. 
The measurements for each group were combined and 
compared for statistical significance using either a paired t-
test or for non parametric data, the Mann-Whitney test. 
Statistical significance was confirmed where p < 0.05. 
RESULTS 
  Morphologically, ovine MSC are a large adherent 
population exhibiting a heterogeneous phenotype including 
cells resembling fibroblasts, polygonal, stellate, and spindle 
shaped cells with long processes (Fig. 1A). Gelfoam, a 
medical device made from porcine skin gelatin and used 
clinically, was used as a scaffold carrier for MSC 
implantation in this study (Fig. 1B). Merino cross lambs (8 
to 10 weeks old) were placed under general anaesthesia, and 
using a high speed dental drill and small dental burr (2 mm), 
a single partial peripheral growth plate defect was created of 
approximately 1 cm
2 (Fig. 1C). In the instance of 
transplantation with scaffold or scaffold plus autologous 
MSC, the Gelfoam implant was easily placed and fit into the 
defect site, and due to the absorbent and spongy 
characteristic of the scaffold, was highly compatible with the 
topography of the defect (Fig. 1D). 206    The Open Orthopaedics Journal, 2010, Volume 4  McCarty et al. 
  The insertion of K-wires proximally and distally to the 
growth plate (Fig. 2A) to measure longitudinal bone growth 
was performed utilising an F-shaped template (Fig. 2B). 
Comparison between the different treatment groups at 5 
weeks post surgery showed there were no statistically 
significant differences in the rate of limb growth in 
comparison to the uninjured control (Fig. 2C). 
  Histological examination of the untreated samples 
revealed extensive bone formation within the defects (Fig. 
3A). Interposition of Gelfoam scaffold alone to the defect 
site, on the other hand, resulted in bone bridge-free repair 
comprised of dense fibrous tissue, fibrous tissue and fat (Fig. 
3B). A bone spur adjacent to the growth plate was observed 
in nearly all samples examined, with some small trabecular 
bone deposits originating from the metaphysis and epiphysis. 
Examination of the tissue formed within the defect site 
following transplantation of Gelfoam scaffold loaded with 
autologous MSC revealed tissue deposits being comparable 
to those in defects treated with scaffold alone (Fig. 3C). 
Although fibrous tissue, fat, and some bone were also 
observed, overall the repair tissue was more cellular and 
extracellular tissue was denser. Although samples treated 
with autologous MSC exhibited a medial bone spur adjacent 
to the growth plate, the bony deposits originated from the 
periphery (mainly metaphyseal region) of the defect, and 
virtually no bone was detected centrally. 
  Quantitative histological analysis (Fig. 3D) of the 
proportions of repair tissues (including bone, dense fibrous 
tissue, fibrous tissue and fat) within the injury site show that 
the predominant tissue observed within the defect site of the 
untreated group was adipose-like tissue (49.4 ± 20.0 % of the 
total injury area), closely followed by bone (30.0 ± 13.8%) 
(Fig.  3E). In contrast, the tissue composition of defects 
treated with Gelfoam scaffold without cells was in the order 
of fat (43.1 ± 13.2%), dense fibrous tissue (29.0 ± 6.3%), 
fibrous tissue (20.0 ± 9.2%) and bone (8.3 ± 1.1%). 
Compared with the untreated control, there was 
approximately 72% reduction in amount of bone formation 
when the interpositional Gelfoam scaffold was applied. 
Moreover, a 14 fold increase in dense fibrous tissue was 
observed. The quantity of fibrous tissue remained consistent, 
with fat content decreasing slightly by approximately one 
 
Fig. (1). Representative example of the morphological phenotype of ovine BM derived MSC (A). BM MNCs were cultured in vitro and 
stained with Toluidine Blue at day 14 (20x). Gelfoam is a naturally occurring scaffold derived from purified porcine gelatin, with a sponge–
like appearance (B). Surgical creation of a growth plate defect and transplantation of Gelfoam scaffold. A medial longitudinal incision was 
made over the proximal tibia. The growth plate can be visualised as the thin white line running along the bottom of the defect. An 
approximately 1 cm
2 excision was made to the growth plate (arrow) using a small dental burr (C). Transplanted Gelfoam scaffold within the 
growth plate defect (arrow) (D). As the scaffold is absorbent and pliable, it can easily be placed within, and completely fill the injury site. 
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tenth. Analysis of growth plate defects treated with Gelfoam 
scaffold and autologous MSC revealed a tissue composition 
consisting of dense fibrous (38.2 ± 6.1%), fibrous (29.6 ± 
10.0%), fat (24.2 ± 6.6%) and bone (7.9 ± 1.8%). In 
comparison to the untreated control, the proportion of bone 
formation decreased by approximately three quarters 
following transplantation of autologous MSC seeded 
Gelfoam scaffold. In addition, a 19 fold increase in dense 
fibrous tissue was observed. The proportion of fibrous tissue 
was over 1.5 times that of the control group, while 
conversely, the proportion of fat was halved. 
  Several differences were observed between treatments 
with the scaffold alone (interpositional) and the scaffold 
seeded with autologous BM MSC. Whilst the proportion of 
bone was equivalent between the two groups, in the group 
treated with scaffold seeded with MSC, fibrous tissue was 
1.5 times greater, and fat content was half that of the scaffold 
only group. Lastly, the amount of dense fibrous tissue in the 
scaffold only treatment was three quarters that of scaffold 
plus MSC. 
DISCUSSION 
  Previous description of growth plate injury in animal 
models have reported bone bridge formation in rats [17-24], 
mice [25], rabbits [26], and dogs [27] 2 to 3 weeks following 
the surgical procedure. Previous ovine studies have 
determined an infiltration of inflammatory cells 4 days post 
surgery, and ossification of the defect site within 14 days 
[11-13], comparable to that observed in rats [19]. To date, 
 
Fig. (2). Kirschner wire (K-wire) marker placement as an indicator of bone growth post operatively. Antero-posterial X-Ray of a lamb tibia 
indicating K-wire marker placement (A). The white arrow indicates the location of the growth plate. Epiphyseal and diaphyseal pins were 
placed 20 mm apart on the day of surgery using an F shaped template to ensure parallel and equidistant insertion of the K-wires (B). The 
distance between the pins was measured using callipers to determine the amount of post-operative limb growth in 5 weeks (C). Total limb 
growth is estimated by the 5-week differences of the distance (mm) of the two implanted K-wires below and above the defect (mean ± SEM), 
showing no statistically significant differences in the rates of limb growth between groups compared to non-injured control. 
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successful repair of growth plate defects using MSC has 
been achieved using agarose, chitin, gelatin and Gelfoam 
composites, and fibrin glue [3-6, 28]. The aforementioned 
studies all utilised a rabbit model, however the therapeutic 
potential of MSCs for growth plate regeneration in larger 
animal models has not been documented. 
  Recently, we demonstrated that adult ovine bone marrow 
aspirates contain a proportion of CFU-F cells with 
phenotypic and functional similarities to human MSC 
capable of multipotential differentiation in vitro and in vivo 
[14]. Undifferentiated ovine BM MSC seeded in Gelfoam 
with TGF-1 form cartilage-like tissue, but not osteogenic 
 
Fig. (3). Surgical creation of a growth plate defect and analysis of repair tissues 5 weeks after untreated or treated with interpositional 
transplantation of Gelfoam scaffold alone or seeded with autologous BM MSC. Representative images of repair tissues on cross sections 
stained with Haematoxylin, Eosin, and Alcian Blue (A-C). The location of the growth plate is indicated by *. A representative example of 
extensive bone bridge formation is observed in the untreated defect (2x) (A). A representative example of growth plate defect treated with 
Gelfoam scaffold only (2x) (B), and defect treated with Gelfoam scaffold and autologous MSC (2x) (C). An example of different tissues 
observed within defect (4x) (D), which include bone (B), fat (F), fibrous tissue (Fi), and dense fibrous tissue (DF). Using Image Analysis 
software, the proportions of each repair tissue type were determined and are presented at the % mean area ± SEM of the total injury area for 
each group (E). Statistical significance between treatment groups is indicated by a * (Mann-Whitney, p < 0.05). 
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tissue, following subcutaneous transplantation in immuno-
comprimised mice [14]. In the current study, Gelfoam 
scaffold was further selected for application in a model of 
growth plate injury for three additional reasons. Firstly, used 
clinically as a haemostatic agent, the intrinsic properties of 
Gelfoam may be beneficial in inhibiting the early 
inflammatory response that occurs following mechanical 
disruption of the growth plate, by physically impeding the 
infiltration of inflammatory cells. Secondly, the topography 
of Gelfoam renders it ideal for implantation in the defect 
created here using a lamb model. Thirdly, the characteristic 
of Gelfoam to withhold a high fluid content within its 
matrices may recapitulate cartilage tissue where the water 
content can extend to 80% of the wet weight. Gelfoam or 
gelatin sponges have been applied in studies examining 
chondrogenesis  in vivo and cartilage repair, using both 
chondrocytes [29, 30] and MSC [3, 31-33]. 
  The current study represents the first work that has 
utilised this ovine large animal model to investigate whether 
bone marrow derived MSC can be used to initiate 
regeneration at the injured growth plate. Results indicated 
that the application of MSC to the site of growth plate injury 
did not result in chondrogenic differentiation or regeneration 
of the damaged cartilage, but formation of dense fibrous 
tissue. The differentiation of cells to form more fibrous 
repair tissue may be attributed to the inflammatory response 
at the injury site, which may overwhelm signals imparted by 
the scaffold and the growth factor. Nonetheless, the 
undesirable bone formation was reduced and most 
importantly, not accelerated at the injury site. The 
application of scaffold without MSC reduced the proportion 
of bony tissue and the repair site contained fibrous tissue 
suggesting the infiltration of endogenous fibroblastic cells to 
the injury site. Taken together, the Gelfoam scaffold does not 
appear to be pro-osteogenic, which is desirable in studies 
addressing cartilage regeneration. 
  Questions to be addressed in the future may include 1) 
analysis of the repair tissue at longer intervals post-
operatively to determine if the repair tissue is maintained and 
bone bridge is prevented long term, and thus whether 
different treatment groups are affecting reaction kinetics 
rather that overall outcome; 2) the potential of MSCs ‘pre-
differentiated/committed’ to chondrogenic lineage in vitro 
prior to transplantation - to improve the possibility of 
chondrogenic tissue repair; 3) tracking of the introduced 
MSCs to determine their role in the repair response - whether 
MSCs directly contribute to the repair tissue or facilitate the 
recruitment of endogenous cells. Further study is required to 
evaluate whether MSC may be a viable therapeutic option 
for the biological regeneration of the growth plate following 
injury. 
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